Connecting personalised medicine research in Canada with Europe

Roche joining forces to forward precision oncology

SABCS 2017: The latest in CDK inhibition in breast cancer

Postmenopausal women who lose weight may have reduced breast cancer risk

Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy

ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence

Predicting late breast cancer recurrence with screening assays

Tandem duplicator phenotypes define 50% of triple negative breast cancers

Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death

The reality of pancreatic cancer

Personalised medicine for inherited breast cancer

Lung cancer screening across Europe